Your browser doesn't support javascript.
loading
Vibegron shows high efficacy in pediatric patients with refractory daytime urinary incontinence.
Hyuga, Taiju; Tanabe, Kazuya; Kubo, Taro; Nakamura, Shigeru; Nakai, Hideo; Moriya, Kimihiko.
Affiliation
  • Hyuga T; Department of Pediatric Urology, Children's Medical Center Tochigi, Jichi Medical University, Shimotsuke, Tochigi, Japan.
  • Tanabe K; Department of Pediatric Urology, Children's Medical Center Tochigi, Jichi Medical University, Shimotsuke, Tochigi, Japan.
  • Kubo T; Department of Pediatric Urology, Children's Medical Center Tochigi, Jichi Medical University, Shimotsuke, Tochigi, Japan.
  • Nakamura S; Department of Pediatric Urology, Children's Medical Center Tochigi, Jichi Medical University, Shimotsuke, Tochigi, Japan.
  • Nakai H; Department of Pediatric Urology, Children's Medical Center Tochigi, Jichi Medical University, Shimotsuke, Tochigi, Japan.
  • Moriya K; Department of Pediatric Urology, Children's Medical Center Tochigi, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Neurourol Urodyn ; 42(4): 794-798, 2023 04.
Article de En | MEDLINE | ID: mdl-36840745
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vessie hyperactive / Énurésie diurne Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Child / Female / Humans / Male Langue: En Journal: Neurourol Urodyn Année: 2023 Type de document: Article Pays d'affiliation: Japon
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vessie hyperactive / Énurésie diurne Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Child / Female / Humans / Male Langue: En Journal: Neurourol Urodyn Année: 2023 Type de document: Article Pays d'affiliation: Japon